Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency

Neuromuscular Disorders

Volumn 22, Issue 8, 2012, Pages 685-689

  Pane, M ^a   Messina, S ^a,b   Vasco, G ^a   Foley, A R ^c   Morandi, L ^d   Pegoraro, E ^e   Mongini, T ^f   D'Amico, A ^g   Bianco, F ^a   Lombardo, M E ^a   Scalise, R ^a   Bruno, C ^h   Berardinelli, A ⁱ   Pini, A ^j   Moroni, I ^d   Mora, M ^d   Toscano, A ^b   Moggio, M ^k   Comi, G ^k   Santorelli, F M ^g   Bertini, E ^g   Muntoni, F ^c   Mercuri, E ^a,c   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ UNIVERSITY OF PAVIA   (Italy)

^j MAGGIORE HOSPITAL   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

Alpha dystroglycan; Congenital muscular dystrophy; Heart; Respiratory

Indexed keywords

ALPHA DYSTROGLYCAN; FUKUTIN RELATED PROTEIN; MANNOSYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN O MANNOSYLTRANSFERASE 1; PROTEIN O MANNOSYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ALPHA DYSTROGLYCAN DEFICIENCY; ARTICLE; ASSISTED VENTILATION; CARDIOVASCULAR FUNCTION; CHILD; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; FKRP GENE; FOLLOW UP; GENE; GENE MUTATION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MITRAL VALVE REGURGITATION; MORTALITY; MUSCULAR DYSTROPHY; NONINVASIVE VENTILATION; POMGNT1 GENE; POMT1 GENE; POMT2 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN GLYCOSYLATION; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BRAIN; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DYSTROGLYCANS; FOLLOW-UP STUDIES; HEART; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MANNOSYLTRANSFERASES; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MUSCULAR DYSTROPHIES; MUTATION; PROTEINS; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; VENTILATORS, MECHANICAL; YOUNG ADULT;

EID: 84863878721     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.05.006     Document Type: Article

References (28)

1. Muntoni F., Brockington M., Godfrey C., et al. Muscular dystrophies due to defective glycosylation of dystroglycan. Acta Myol 2007, 26:129-135.
2. Beltran-Valero de Bernabè D., Currier S., Steinbrecher A., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002, 71:1033-1043.
3. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001, 69:1198-1209.
4. Kobayashi K., Nakahori Y., Miyake M., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998, 394:388-392.
5. Longman C., Brockington M., Torelli S., et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 2003, 12:2853-2861.
6. van Reeuwijk J., Janssen M., van den Elzen C., et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 2005, 42:907-912.
7. Yoshida A., Kobayashi K., Manya H., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001, 1:717-724.
8. Lefeber D.J., Schonberger J., Morava E., et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet 2009, 85:76-86.
9. Godfrey C., Clement E., Mein R., et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007, 130:2725-2735.
10. Mercuri E., Messina S., Bruno C., et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology 2009, 72:1802-1809.
11. Nadeau A., Kinali M., Main M., et al. Natural history of Ullrich congenital muscular dystrophy. Neurology 2009, 73:25-31.
12. Finsterer J., Ramaciotti C., Wang C.H., et al. Cardiac findings in congenital muscular dystrophies. Pediatrics 2010, 126:538-545.
13. Brown S.C., Torelli S., Brockington M., et al. Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol 2004, 164:727-737.
14. Dubowitz V., Sewry C.A. Muscle biopsy - a practical approach 2007, Saunders.
15. Mercuri E., Brockington M., Straub V., et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 2003, 53:537-542.
16. Murakami T., Hayashi Y.K., Noguchi S., et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 2006, 60:597-602.
17. Nakanishi T., Sakauchi M., Kaneda Y., et al. Cardiac involvement in Fukuyama-type congenital muscular dystrophy. Pediatrics 2006, 117:1187-1192.
18. Yanagisawa A., Bouchet C., Van den Bergh P.Y., et al. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation. Neurology 2007, 69:1254-1260.
19. Poppe M., Bourke J., Eagle M., et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 2004, 56:738-741.
20. Margeta M., Connolly A.M., Winder T.L., et al. Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I. Muscle Nerve 2009, 40:883-889.
21. Gaul C., Deschauer M., Tempelmann C., et al. Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 2006, 253:1317-1322.
22. Kefi M., Amouri R., Chabrak S., Mechmeche R., Hentati F. Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations. Neuropediatrics 2008, 39:113-115.
23. Louhichi N., Triki C., Quijano-Roy S., et al. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families. Neurogenetics 2004, 5:27-34.
24. MacLeod H., Pytel P., Wollmann R., et al. A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex. Neuromuscul Disord 2007, 17:285-289.
25. Messina S., Tortorella G., Concolino D., et al. Congenital muscular dystrophy with defective alpha-dystroglycan, cerebellar hypoplasia, and epilepsy. Neurology 2009, 73:1599-1601.
26. Kanoff R.J., Curless R.G., Petito C., et al. Walker-Warburg syndrome: neurologic features and muscle membrane structure. Pediatr Neurol 1998, 18:76-80. Review.
27. Santavuori P., Valanne L., Autti T., et al. Muscle-eye-brain disease: clinical features, visual evoked potentials and brain imaging in 20 patients. Eur J Paediatr Neurol 1998, 2:41-47.
28. Hehr U., Uyanik G., Gross C., et al. Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease. Neurogenetics 2007, 8:279-288.